Watchlist Signal

Fractionated dose of 225Ac-J591

Fractionated dose of 225Ac-J591 is flagged as watchlist signal because public records show timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Prostate Cancer

Mechanism: Unknown

Modality: Unknown

Sponsor: Weill Medical College of Cornell University

Scores

Risk-signal summary

Registry: 1/5

Timeline: 2/5

Recruitment burden: 0/5

Results availability: 0/5

Program risk: 2/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT04506567

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT04506567Low Signal (ACTIVE_NOT_RECRUITING)primary_completion_date_past_signal | long_recruitment_duration_signalLow SignalNone